Sandbox GGC16

PU.1 is a hematopoietic transcription factor. It specifically regulates transcription of genes specific to lymphoid cells, ultimately leading to cellular differentiation.^[1] This transcription factor binds DNA with its helix-turn-helix motif.

Function

Within the nucleus, PU.1 activates transcription of lymphoid genes by binding DNA during hematopoiesis. The name PU.1 comes from the protein's binding interactions with a purine-rich DNA sequence.

Activation

A post-translational modification of PU.1 occurs at a serine residue (residue 41). This phosphorylation by protein kinase B (AKT) induces PU.1 activation.^[2]

Binding Domain

Ets binding domain is conserved across the Ets family of proteins which consist of about 35 proteins with similar functions. Binding domain is positively charged. Residues most closely interacting with DNA include Arginine and Lysine. These are highly conserved- the two Arginines on the central helix within the major groove of the DNA and two Lysines on the outer turns.^[3]

Disease

PU.1 has been identified as an oncogene. Mutations have been identified in patients with leukemias and lymphomas. Interestingly, the mutations are not always identified within the binding site.

PEST domain

The PEST domain is adjacent to the binding domain and has been found mutated in leukemia patients.^[4] It is highly polar due to the abundance of proline, glutamate, serine, and threonine. Proteins with a PEST region typically have a short half-life of under 2 hours. It is hypothesized that the PEST region is a tag for fast degradation of the protein.

References

1. ↑ UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. (2021, April 7). Transcription factor PU.1. UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. https://www.uniprot.org/uniprot/P17947.
2. ↑ Rieske, P., & Pongubala, J. M. R. (2001). AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain. Journal of Biological Chemistry, 276(11), 8460–8468. https://doi.org/10.1074/jbc.m007482200
3. ↑ Kodandapani, R., Pio, F., Ni, CZ. et al. A new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex. Nature 380, 456–460 (1996). https://doi.org/10.1038/380456a0
4. ↑ Mueller, B. U. Heterozygous PU.1 Mutations Are Associated with Acute Myeloid Leukemia. Blood. 2003, 101(5), 2074–2074.